Sangamo Therapeutics Inc (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,545 | -85,217 | -49,089 | -257,831 | -197,536 |
| Depreciation Amortization | 6,953 | 4,826 | 2,253 | 109,348 | 106,637 |
| Income taxes - deferred | 18 | N/A | 0 | -6,335 | -6,195 |
| Accounts receivable | -9,171 | 712 | 232 | 2,755 | 2,722 |
| Other Working Capital | -10,830 | -7,490 | -7,504 | -160,303 | -164,817 |
| Other Operating Activity | 23,787 | 11,622 | 5,445 | 87,524 | 84,885 |
| Operating Cash Flow | $-63,788 | $-75,547 | $-48,663 | $-224,842 | $-174,304 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 35,840 | 35,840 | 35,840 | 174,686 | 134,307 |
| PPE Investments | 360 | N/A | N/A | -21,155 | -18,484 |
| Other Investing Activity | 0 | 127 | 0 | 0 | 0 |
| Investing Cash Flow | $36,200 | $35,967 | $35,840 | $153,531 | $115,823 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 22,070 | 22,070 | 22,524 | 16,041 | 15,825 |
| Other Financing Activity | -684 | -481 | -402 | -1,453 | -1,404 |
| Financing Cash Flow | $21,386 | $21,589 | $22,122 | $14,588 | $14,421 |
| Exchange Rate Effect | 199 | -927 | -670 | 1,483 | 130 |
| Beginning Cash Position | 46,704 | 46,704 | 46,704 | 101,944 | 101,944 |
| End Cash Position | 40,701 | 27,786 | 55,333 | 46,704 | 58,014 |
| Net Cash Flow | $-6,003 | $-18,918 | $8,629 | $-55,240 | $-43,930 |
| Free Cash Flow | |||||
| Operating Cash Flow | -63,788 | -75,547 | -48,663 | -224,842 | -174,304 |
| Capital Expenditure | -115 | 0 | N/A | -21,155 | -18,484 |
| Free Cash Flow | -63,903 | -75,547 | -48,663 | -245,997 | -192,788 |